Gender-Based Outcomes Differences in Unresectable Hepatocellular Carcinoma

Hepatology International - India
doi 10.1007/s12072-007-9041-2
Full Text
Abstract

Available in full text

Categories
Hepatology
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Sorafenib for the Treatment of Unresectable Hepatocellular Carcinoma

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2008English

Network Meta-Analysis of Treatments for Unresectable Hepatocellular Carcinoma

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Lenvatinib and Its Use in the Treatment of Unresectable Hepatocellular Carcinoma

Future Oncology
MedicineCancer ResearchOncology
2018English

Feasibility and Efficacy of Helical Tomotherapy in Cirrhotic Patients With Unresectable Hepatocellular Carcinoma

World Journal of Surgical Oncology
SurgeryOncology
2015English

Circulating Tumour Cells as Biomarkers for Evaluating Cryosurgery on Unresectable Hepatocellular Carcinoma

Oncology Reports
MedicineCancer ResearchOncology
2016English

Sorafenib Continuation or Discontinuation in Patients With Unresectable Hepatocellular Carcinoma After a Complete Response

Oncotarget
Oncology
2015English

Regional Differences in Hepatocellular Carcinoma and Its Surgical Treatment

HPB Surgery
SurgeryHepatology
1991English

Yttrium-90 Radioembolization Versus Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Comparative Analysis

HPB
HepatologyGastroenterology
2016English

Histopathologic Outcomes After Bland Embolization of Hepatocellular Carcinoma

Journal of Vascular and Interventional Radiology
Nuclear MedicineRadiologyCardiologyCardiovascular MedicineImagingMedicine
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy